Psychiatry News and Research

RSS

Psychiatry is the treatment, study and prevention of mental disorders.

COVID-19 survivors at increased risk of psychiatric disorders, study finds

Researchers at the University of Oxford, Department of Psychiatry and NIHR Oxford Health Biomedical Research Centre, report the first large-scale evidence that COVID-19 survivors are at an increased risk of psychiatric disorders.

10 Nov 2020

Scientist develop compact, portable sanitizing device for masks and other items

COVID-19 has significantly increased public use of face masks to protect others from the wearer's respiratory droplets as well as the wearer from airborne contaminants.

10 Nov 2020

New evidence of neurobiological mechanism for hallucinations and delusions found

A new study from researchers at Columbia University Vagelos College of Physicians and Surgeons has found evidence of a potential neurobiological mechanism for hallucinations and delusions that fits within the hierarchical model of psychosis and can explain their clinical presentation.

9 Nov 2020

OCD, anxiety and depressive symptoms worsen in young people during COVID-19

Many children and young people with obsessive thoughts and compulsions experience that their OCD, anxiety and depressive symptoms worsen during a crisis such as COVID-19.

9 Nov 2020

Delirium common after hospital discharge in critically ill COVID-19 patients

Anesthesiologist and other researchers from Michigan Medicine, Ann Arbor, New York Medical College, Valhalla and Center for Consciousness Science, University of Michigan Medical School, Ann Arbor, have reported a case series of critically ill coronavirus disease 2019 (COVID-19) patients who have developed neuropsychological symptoms after having been discharged from the hospital.

8 Nov 2020

Natural component of ayahuasca tea promotes neurogenesis

One of the main natural components of ayahuasca tea is dimethyltryptamine (DMT), which promotes neurogenesis --the formation of new neurons-- according to research led by the Complutense University of Madrid (UCM).

6 Nov 2020

COVID-19 patients who experience strokes appear to have worse outcomes

People who experience strokes while infected with COVID-19 appear to be left with greater disability after the stroke, according a study led by UCL and UCLH researchers.

5 Nov 2020

Providing the best psychiatric care within a safe environment during COVID-19 pandemic

The very heart of inpatient care for psychiatric patients is socialization, group therapy, shared meals, and a standard two people per room. Then COVID-19 hit with the accompanying public health warnings to isolate, socially distance, and wear masks.

4 Nov 2020

App-delivered computerized brain-training helps prevent alcohol relapse

A recent study has shown that it may be possible to dampen the workings of the subconscious brain to prevent alcohol relapse, the results leading to a world-first trial of a personalised smartphone app called "SWiPE".

4 Nov 2020

Psilocybin may be effective in patients suffering from major depression

In a small study of adults with major depression, Johns Hopkins Medicine researchers report that two doses of the psychedelic substance psilocybin, given with supportive psychotherapy, produced rapid and large reductions in depressive symptoms, with most participants showing improvement and half of study participants achieving remission through the four-week follow-up.

4 Nov 2020

Earwax sampling could be a cheap, effective way to measure stress hormone

A novel method to sample earwax could be a cheap and effective way to measure the hormone cortisol, according to a study led by researchers at UCL and King's College London.

3 Nov 2020

Study finds variation in the effectiveness of collaborative care for depression

In the United States, more than half of people living with a mental health disorder do not receive treatment, according to the National Institute of Mental Health, which is why primary-care clinics can play a leading role in depression care.

3 Nov 2020

Children with minor perinatal brain bleeds have normal cognitive development at two years of age

In 2007, UNC researchers published unexpected and surprising results from a study based on magnetic resonance imaging (MRI) of newborn brains.

30 Oct 2020

Addictive drug displays different acute pharmacology and synaptic plasticity

Nucleus accumbens in the brain play a central role in the risk-reward circuit. Their operation is based chiefly on three essential neurotransmitters: dopamine, which promotes desire; serotonin, whose effects include satiety and inhibition; and glutamate, which drives goal-directed behaviors and responses to reward-associated cues and contexts.

30 Oct 2020

Remdesivir received FDA approval for treating COVID-19 patients: Benefits still not proven

The United States has become the epicenter of the world in the ever increasing pandemic of COVID-19. While public health prevention strategies of social distancing, crowd avoidance, masking and frequent hand washing are of proven benefit, effective drug therapies for treatment are sparse.

29 Oct 2020

McLean Hospital joins public-private partnership to find cure for schizophrenia

In September, McLean Hospital joined the National Institutes of Health, the U.S. Food and Drug Administration, and several public and private organizations to find early therapeutic interventions for people at risk for schizophrenia.

29 Oct 2020

Sleep could be targeted to improve post-stroke recovery, study shows

Until today neurorehabilitation is the only approach that promotes recovery after stroke. Researchers at the Neurology Department of the University of Bern and Inselspital have provided first evidence that sleep could be targeted to improve post-stroke recovery.

28 Oct 2020

Readers and tweeters shed light on vaccine trials and bias in health care

In the piece about the AstraZeneca vaccine trial subject who suffered severe spinal cord inflammation, that person was repeatedly referred to as a "patient" ("NIH 'Very Concerned' About Serious Side Effect in Coronavirus Vaccine Trial," Sept. 14).

28 Oct 2020

Scientists receive $3.9 million to optimize treatment for opioid use disorder

Drawing upon their experience and expertise in telehealth, collaborative care models, substance use disorders, depression and health information technology, Indiana University School of Medicine and Regenstrief Institute faculty have been awarded $3.9 million over four years to collaborate with Kaiser Permanente Washington Health Research Institute scientists on a trial to optimize treatment for opioid use disorder.

28 Oct 2020

Powerful drug used in chemotherapy could alleviate hallucinations in Parkinson's patients

A world-first double-blind clinical trial, will investigate if a powerful drug used to treat nausea in chemotherapy patients, could alleviate hallucinations in people with Parkinson's.

27 Oct 2020